Lung Cancer

Certain retinoids able to override nicotine effects better than others

Published in Gene Therapy Weekly, July 25th, 2002

by Sonia Nichols, senior medical writer - Clinical trials suggesting that common retinoids have little value for overriding the effects of nicotine in cigarette smokers may have been using the wrong type of retinoids, according to researchers at a major cancer research center.

Investigators at the Burnham Institute Cancer Center in La Jolla, California, recently suggested that RXR [rentinoid X receptor]-selective retinoids, rather than classical retinoids, may be able to overcome nicotine-related inhibition of tumor suppression, tumor providing a novel way to treat or prevent lung cancer.

In preliminary studies of lung cancer, G.Q. Chen and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry